About the company

We are a R&D-driven company engaged in the development of Class III and Class C/D medical devices, with an emphasis onVascular Intervention (“VI”) and Structural Heart (“SH”). According to the F&S Report, VI refers to minimally invasiveprocedures used to diagnose or treat diseases of the blood vessels, while SH intervention refers to minimally invasive proceduresused to treat defects or abnormalities in the heart’s structure. Our portfolio of (i) VI products includes coronary interventionproducts such as coronary stents and coronary balloons, (ii) SH products includes Trans-Catheter Aortic Valve (“TAVI”) andOccluders, and (iii) other products (“Others”) including our own brand of renal stents, peripheral DCBs and other tradingproducts.

Company Financials